Home LiteratureArticle Details
PMID: 11861399 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Low-level microsatellite instability in most colorectal carcinomas.

Cancer research ·Vol. 62 ·No. 4 ·2002-02-15 ·Pages 1166-70

Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Järvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS, Aaltonen LA

Abstract

Twelve to 16% of colorectal cancers (CRCs) display a high degree of microsatellite instability (MSI-H), whereas most are believed to be microsatellite stable (MSS). The existence of a low degree of instability (MSI-L) group has also been proposed. By using the Bethesda panel of microsatellite markers, the microsatellite instability (MSI) status of CRCs can be determined. This set is recommended to distinguish between MSI-H and MSI-L/MSS. No definition for MSI-L has emerged. Most reports on MSI-L rely on the Bethesda panel, using 5-15markers. Tumors with more than 30% MSI are designated as MSI-H, but the lower limit for MSI-L is ambiguous. We hypothesized that if many markers are studied, almost all CRCs would show some MSI. It would be necessary to establish a cutoff level for MSI-L by showing that, above this cutoff level, tumors display molecular and/or clinical features different from those under the cutoff level. To perform this task, we analyzed 90 BAT26 stable CRC samples with 377 markers. MSI at 1-11 loci was observed in 71 (79%) of the 90 cases. K-RAS mutation, loss of heterozygosity, and MLH1 and MGMT hypermethylation analyses were performed, as well as clinical features being scrutinized, to examine possible differences between MSI-L and MSS tumors using all of the possible cutoff levels for MSI-L. Convincing differences between putative MSI-L and MSS groups were not observed. Our results show that the sensitivity of a typically used marker number to detect MSI-L is very low, and they suggest that MSS and MSI-L tumors have a common molecular background.

MeSH Terms
Adaptor Proteins, Signal Transducing Adult Aged Aged, 80 and over Carrier Proteins Colorectal Neoplasms/genetics,pathology Female Genes, ras Humans Male Microsatellite Repeats/genetics Middle Aged MutL Protein Homolog 1 Mutation Neoplasm Proteins/genetics Nuclear Proteins O(6)-Methylguanine-DNA Methyltransferase/genetics
Chemicals
Adaptor Proteins, Signal Transducing Carrier Proteins MLH1 protein, human Neoplasm Proteins Nuclear Proteins O(6)-Methylguanine-DNA Methyltransferase MutL Protein Homolog 1
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Laiho Päivi
Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, FIN-00014 Helsinki, Finland.
Launonen Virpi
Lahermo Päivi
Esteller Manel
Guo Mingzhou
Herman James G
Mecklin Jukka-Pekka
Järvinen Heikki
Sistonen Pertti
Kim Kyoung-Mee
Shibata Darryl
Houlston Richard S
Aaltonen Lauri A
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2002-02-15
Pages
1166-70
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com